Search
for
Sort by
Research 61–90 of 1000+
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- What is the Rationale for Androgen Therapy for Women?
- Androgen replacement therapy in women
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Androgens in women
- Androgens and the Menopause
- Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis
- The rationale for physiological testosterone replacement in women
- Changes of androgens levels in menopausal women
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Contraceptive use in acne
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- 46, XY Disorder of Sexual Development with Ambiguous Female External Genitalia: A Case Report
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- The skin and obesity
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW
- Androgen treatment in women
- Approach to the adult female patient with diffuse nonscarring alopecia
- Menstrual Irregularity in Women with Acromegaly
- Nonclassic adrenal hyperplasia
- Dermatoses of pregnancy
- Gender Differences in Cardiac Hypertrophy
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Transgender and Migraine
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien